| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008727 | Annals of Allergy, Asthma & Immunology | 2005 | 6 Pages |
Abstract
In this analysis, patients receiving FSC had lower rates of asthma-related symptoms and exacerbations as measured by SABA refills and hospitalization, respectively, when compared with patients receiving either FP or FP + SAL. This observational examination of medical and pharmacy claims data adds to the clinical reports that demonstrate the increased effectiveness of FSC when compared with FP or FP + SAL.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Richard D. MD, Jacqueline R. Carranza PharmD, Richard H. PharmD, Amanda S. MPH, Kira L. BA, Antonio P. MD, MPH, David A. MD,